Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
WHO Concern as Monkeypox Cases Jump by 77% in a Week 07/07/2022 Kerry Cullinan With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Posts navigation Older postsNewer posts